LabCorp (LH)
| Market Cap | 23.02B |
| Revenue (ttm) | 13.98B |
| Net Income (ttm) | 1.56B |
| Shares Out | 97.40M |
| EPS (ttm) | 15.88 |
| PE Ratio | 14.86 |
| Forward PE | 11.61 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | February 26 |
| Last Price | $235.99 |
| Previous Close | $236.53 |
| Change ($) | -0.54 |
| Change (%) | -0.23% |
| Day's Open | 237.38 |
| Day's Range | 234.09 - 239.38 |
| Day's Volume | 446,993 |
| 52-Week Range | 98.02 - 252.45 |
Jana Partners (Trades, Portfolio), a New York-based investment firm, disclosed last week that its top four trades during the fourth quarter of 2020 featured new holdings in Laboratory Corp of ...
DEERFIELD, Ill. & BURLINGTON, N.C.--(BUSINESS WIRE)--As part of Walgreens ongoing efforts to increase access to COVID-19 testing in communities across the U.S., the company announced today it ...
Pacific Biosciences' (PACB) Sequel II HiFi sequencing gets utilized by LabCorp to detect SARS-COV-2 variants in the United States.
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced that members of the executive management team will participate in a virtual fires...
LabCorp's (LH) new antigen test is the newest development to detect COVID-19 infection at every single stage, from diagnostic testing to vaccination trails.
Rebound in sales volumes and rise in COVID-19 support products sales make us optimistic about MDT, MASI, XRAY and COO's results.
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced the availability of a new laboratory-based antigen test that will help doctors de...
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced that Amy Summy, executive vice president and chief marketing officer, was recogni...
The laboratory services giant continued to profit mightily from its COVID-19 testing business.
LabCorp's (LH) 2021 guidance projects significant downfall in COVID-related testing revenues.
LabCorp (LH) delivered earnings and revenue surprises of 31.18% and 12.94%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading life sciences company, today announced results for the fourth quarter and year ended December 31, 2020, and full year 2021 guid...
LabCorp (LH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced the appointments of Prasanth Reddy, MD, MPH, and Robert Phillips, PhD, to its onc...
LabCorp's (LH) fourth-quarter base-business performance is expected to have registered slower recovery rate compared to the third quarter.
LabCorp is benefitting from the recent surge in COVID infections, and the new COVID variants should keep up demand for its services. It continues to build its healthcare footprint and expand i...
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has been named to FORTUNE® magazine's 2021 List of World's Most Admired C...
LabCorp (LH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp, (NYSE: LH), a leading global life sciences company, announced today that Dr. Deborah Ann Sesok-Pizzini has been appointed Chief Medical Officer of L...
The resurgence in coronavirus infections is drawing attention back to the diagnostic testing space.
"We still have to understand a lot more about the vaccines, know what to measure, how to measure," LabCorp CEO Adam Schechter told CNBC.
LabCorp CEO discusses Covid mutations
Adam Schechter, LabCorp CEO, joins 'Closing Bell' to discuss the state of testing in the U.S., Covid mutations and his thoughts on what it will take to reach herd immunity.
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, will release its fourth quarter and full year 2020 financial results before the market opens on T...
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has been awarded a contract from the Centers for Disease Control and Prev...
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced that Dr. Brian Caveney, chief medical officer and president of Labcorp Diagnostic...
Apart from COVID-19 supports, LabCorp (LH) is making significant strides in other businesses.
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced that members of the executive management team will participate in a virtual fires...
Top Ranked Growth Stocks to Buy for January 4th
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to th...
Top Ranked Growth Stocks to Buy for December 30th
P/B ratio is emerging as a convenient tool to identify low-priced stocks that have high growth prospects.
Value investing is essentially about selecting stocks that are usually cheap but fundamentally sound. ODP Corporation (ODP), Sanmina Corporation (SANM), Laboratory Corporation (LH) and Boise C...
LabCorp (LH) closed at $203.87 in the latest trading session, marking a -0.09% move from the prior day.
Top Ranked Growth Stocks to Buy for December 23rd
LabCorp (LH) possesses solid growth attributes, which could help it handily outperform the market.
DEERFIELD, Ill. & BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company that is focused on advancing health and guiding patient care decisions, and Walg...
LabCorp (LH) closed at $205.11 in the latest trading session, marking a +1.19% move from the prior day.
LH vs. XRAY: Which Stock Is the Better Value Option?
We have screened bargain stocks ODP Corp. (ODP), Laboratory Corporation of America (LH), Boise Cascade (BCC), Koppers (KOP) and Greif (GEF) based on EV-to-EBITDA ratio that offers a clearer pi...
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to th...
Top Ranked Growth Stocks to Buy for December 15th
Coronavirus testing: LabCorp receives FDA authorization for at-home COVID-19 kits
Yahoo Finance's Alexis Christoforous and Brian Caveney, Labcorp Diagnostics President, discuss the latest at-home COVID-19 test kit. #coronavirustest #COVID19testing #athomecovidtest #athomeco...
This approval is expected to increase access to LabCorp's (LH) COVID-19 testing, thereby broadening its customer base.
LabCorp has now become the first company to receive approval to sell its COVID-19 test kit over-the-counter without a prescription, according to a statement form the company. One of the larges...
LabCorp Receives FDA Authorization to Make At-Home COVID-19 Collection Kits Available Through Retail
BURLINGTON, N.C.--(BUSINESS WIRE)--LabCorp (NYSE: LH), a leading global life sciences company that is focused on advancing health and guiding patient care decisions, today announced that the U...
Is Laboratory Corporation (LH) a great pick from the value investor's perspective right now? Read on to know more.
Top Ranked Growth Stocks to Buy for December 9th
Our indicative theme of Covid-19 Testing Stocks- which includes the stocks of companies that produce or carry out tests for the highly infectious virus - is up by about 51% year-to-date, on an...
In oncology too, LabCorp (LH) receives a significant award to be the partner of choice for late-stage oncology studies from a major pharmaceutical company.
Top Ranked Growth Stocks to Buy for December 7th
About LH
Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates in two segments, LabCorp Diagnostics (LCD) and Covance Drug Development. It offers various clinical laboratory tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C and vitamin D products, prostate-specific antigens, tests for sexually-transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The compan... [Read more...]
| Industry Diagnostics & Research | Founded 1971 |
| CEO David King | Employees 75,000 |
| Stock Exchange NYSE | Ticker Symbol LH |
Financial Performance
In 2020, LabCorp's revenue was $13.98 billion, an increase of 20.98% compared to the previous year's $11.55 billion. Earnings were $1.56 billion, an increase of 88.89%.
Analyst Forecasts
According to 18 analysts, the average rating for LabCorp stock is "Buy." The 12-month stock price forecast is 269.85, which is an increase of 14.35% from the latest price.